专利号:US-5041526-A 优先权日:1988-05-16 标 题:Dimer for synthesis of high performance polymer matrix composites 发明人:RIEL FRANK J; VUONG TUYET; DELANEY EDWARD A 权利人:ROHR INDUSTRIES INC 摘要:An improved synthesis for PMR-type polyimides, including first preparing a dimer of 5-norbornene-2,3-dicarboxylic acid, or acid ester or anhydride and 4,4'methylene dianiline. This dimer is then reacted with one of the following: n 1. the reaction product of a primary aromatic diamine and an aromatic dianhydride. n 2. an aromatic dianhydride. n 3. a mixture of a primary aromatic diamine and an aromatic dianhydride, or an ester of an aromatic tetraacid or an aromatic tetraacid. n The resulting polyimide prepolymer exhibits superior physical properties and is substantially free of undesired impurities and unreacted 4,4'-methylene dianiline.
专利号:US-11612614-B2 优先权日:2020-10-20 标题:Isomorphs of Remdesivir and methods for synthesis of same 发明人:TRIPATHI VINAY SHANKAR; PATEL AKSHAY NIKHIL 权利人:ANZALP PHARMASOLUTIONS PVT LTD 摘要:A new isoform of 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3/4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate (Remdesivir) having increased water solubility is disclosed, along with methods for making the same. Also disclosed are solid and liquid pharmaceutical compositions suitable for treating viral infections such as Arenaviridae, Coronaviridae, Filoviridae, Flaviviridae, or Paramyxoviridae viral infections which contain an effective amount of Remdesivir prepared according to the inventive method and the use of those compositions for treating such viral infections.
专利号:US-2025115610-A1 优先权日:2021-08-03 标 题:Process for the catalytic glycosylation of arenes 发明人:LIST BENJAMIN; OBRADORS CARLA; MITSCHKE BENJAMIN; AUKLAND MILES 权利人:STUDIENGESELLSCHAFT KOHLE GGMBH 摘要:The present invention refers to a process for the catalytic glycosylation of arenes which allows, amongst others, the expeditious synthesis of the nucleoside analogue GS-441524 of the antiviral prodrug remdesivir.
专利号:WO-2024193457-A1 优先权日:2023-03-20 标题:Preparation method of pyrrolotriazine compound 发明人:ZHENG CHENGUANG; GUO SONGJING; ZHAO REN; PAN RUI; WANG TAO; TANG PINGSHENG; JIN YEHUA; ZHU WEI; MENG YANHUA 权利人:ZHEJIANG HUAHAI PHARM CO LTD 摘要:The present invention belongs to the field of drug synthesis, and more specifically relates to a preparation method of a pyrrolotriazine compound, specifically comprising: firstly reacting compound 2 with NaH and TMSCl to protect the amino group, and then reacting with compound 3 under the action of n-butyl lithium to obtain compound 4; compound 2 can be obtained by reacting compound 1 with a bromination reagent, and compound 1 can be recovered. The method of the present invention is simple to operate, low in cost, and more conducive to industrial production.
专利号:US-11155675-B2 优先权日:2016-07-27 标 题:Method of regioselective synthesis of polyesters from asymmetric diols 发明人:NODARI MIRCO; LONGO ALDO; COLONNA MARTINO; GIOIA CLAUDIO 权利人:VERSALIS SPA 摘要:A method for synthesizing regioregular polyesters, starting from asymmetric diols, may provide the polymer ordered structure and advantageous physical-chemical properties. Such methods can make it is possible to obtain regioregular polyesters having high glass transition temperatures T g and crystalline properties. In the case in which the asymmetric diols are used in a pure enantiomeric form, with respect to the chiral carbon bound to the secondary hydroxyl, through the above-mentioned method it is possible to obtain regioregular and stereoregular polyesters, which may have thermal and crystalline properties further ameliorative with respect to non-chiral regioregular polymers.
专利号:US-2021161927-A1 优先权日:2020-10-20 标 题:Isomorphs of remdesivir and methods for synthesis of same
1: Van der Walt M, Jones SE, Levy JK, Hart E, Negash R, Novicoff WM, Jacque N, Evans SJM. Clinical Features and Outcomes of Treatment for Effusive Feline Infectious Peritonitis with GS-441524 in Seventeen Retrovirus-Positive Cats. Pathogens. 2026 Mar 21;15(3):337. doi: 10.3390/pathogens15030337. 2: Cooke SW, Hammond R, Gunn-Moore DA. Therapeutic Drug Monitoring of GS-441524 in Cats with Feline Infectious Peritonitis: Pharmacokinetic Variability and Implications for Dose Optimization. Pathogens. 2026 Mar 6;15(3):291. doi: 10.3390/pathogens15030291. 3: Kamiyoshi T, Kamiyoshi N, Jintake C. EXPRESS: High-dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir and GS-441524. J Feline Med Surg. 2026 Mar